These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2149919)

  • 1. Effects of trospectomycin on serum sensitivity of Escherichia coli UC 9451.
    Cialdella JI; Ulrich RG; Liggett WF; Adams LD; Marshall VP
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2086-92. PubMed ID: 2149919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antibacterial activity of trospectomycin (U-63366F), a novel spectinomycin analog.
    Zurenko GE; Yagi BH; Vavra JJ; Wentworth BB
    Antimicrob Agents Chemother; 1988 Feb; 32(2):216-23. PubMed ID: 2966608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trospectomycin enhances surface phagocytosis of Bacteroides and Staphylococcus by altering the bacterial glycocalyx.
    Veringa EM; Ferguson DA; Lambe DW; Verhoef J
    Zentralbl Bakteriol; 1989 Sep; 271(3):311-20. PubMed ID: 2529862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bactericidal activity and postantibiotic effect of trospectomycin.
    Yagi BH; Schaadt RD; Zurenko GE
    Diagn Microbiol Infect Dis; 1992 Jul; 15(5):417-23. PubMed ID: 1386566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity against aerobes and anaerobes of trospectomycin versus spectinomycin.
    Gismondo MR; Chisari G; Lo Bue AM
    Drugs Exp Clin Res; 1991; 17(2):101-4. PubMed ID: 1830841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antibacterial activity of trospectomycin (U-63,366F) against anaerobic bacteria and aerobic gram-positive cocci in Chile.
    Montiel F; Kaltwasser G; Pinto ME; Lam M
    Diagn Microbiol Infect Dis; 1991; 14(3):259-64. PubMed ID: 1832369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of bacteria to serum lysis or phagocytosis following growth in subinhibitory levels of lincosaminide or spectinomycin related antibiotics.
    Cialdella JI; Vavra JJ; Marshall VP
    J Antibiot (Tokyo); 1986 Jul; 39(7):978-84. PubMed ID: 2944862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of trospectomycin (U-63366F) and initial evaluations of disk diffusion susceptibility tests.
    Barry AL; Jones RN; Thornsberry C
    Antimicrob Agents Chemother; 1989 Apr; 33(4):569-72. PubMed ID: 2524997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenylylation of trospectomycin by crude enzyme preparations from Escherichia coli.
    Yagi Y; Baczynskyj L; Mizsak SA; Argoudelis AD
    J Antibiot (Tokyo); 1988 Oct; 41(10):1452-61. PubMed ID: 2973455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activity in vitro of trospectomycin sulphate (U-63366F) against aminoglycoside-resistant enterococci.
    Khardori N; Gandhi M; Adame J; Kalvakuntla L; Rosenbaum B; Bodey GP
    J Antimicrob Chemother; 1990 May; 25(5):777-85. PubMed ID: 2142683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of trospectomycin against Bacteroides fragilis and other Bacteroides species.
    Jacobus NV; Tally FP
    Antimicrob Agents Chemother; 1988 Apr; 32(4):584-6. PubMed ID: 2967671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibilities of oral pigmented Bacteroides species to trospectomycin and other selected antimicrobial agents.
    Johnson CC; Wendeler M; Levison ME
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1597-9. PubMed ID: 2145801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined activity of trospectomycin and colloidal bismuth subcitrate against Helicobacter pylori in vitro.
    Vogt K; Rodloff AC; Hahn H
    Infection; 1991; 19(3):138-9. PubMed ID: 1832417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of subinhibitory concentrations of clindamycin and trospectomycin on the adherence of Staphylococcus epidermidis in an in vitro model of vascular catheter colonization.
    Khardori N; Wong E; Nguyen H; Jeffery-Wiseman C; Wallin E; Tewari RP; Bodey GP
    J Infect Dis; 1991 Jul; 164(1):108-13. PubMed ID: 1829103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of trospectomycin (U-63366F), a novel spectinomycin analog, against gram-positive isolates from cancer patients.
    Rolston K; Ho DH; Bodey GP
    Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):254-60. PubMed ID: 2523806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activity of trospectomycin sulphate against Mycoplasma and Ureaplasma species isolated from humans.
    Yancey RJ; Klein LK
    J Antimicrob Chemother; 1988 Jun; 21(6):731-6. PubMed ID: 2970452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human safety and pharmacokinetics of a single intramuscular dose of a novel spectinomycin analog, trospectomycin (U-63,366F).
    Novak E; Paxton LM; Bye A; Patel R; Zurenko GE; Francom SF
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2342-7. PubMed ID: 2150907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro activity of trospectomycin against anaerobic bacteria.
    Chisari G; Lo Bue AM; Nicoletti G
    J Chemother; 1995 Dec; 7(6):515-8. PubMed ID: 8667035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
    Tesh VL; Duncan RL; Morrison DC
    J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of trospectomycin against enterococci isolated from blood and other clinical materials.
    Watanakunakorn C
    J Antimicrob Chemother; 1991 Jun; 27(6):873-5. PubMed ID: 1834622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.